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Crystal structures of inactive PAK1(K299R) and the
activation (A)-loop phospho-mimetic PAK1(T423E)
have suggested that the kinase domain is in an active
state regardless of activation loop status. Contrary to
a large body of literature, we find that neither is
PAK1(T423E) active in cells, nor does it exhibit signif-
icant activity in vitro. To explain these discrepancies
all-atom molecular dynamics (MD) simulations of
PAK1(phospho-T423) in complex with ATP and
substrate were performed. These simulations point
to a key interaction between PAK1 Lys308, at the
end of the aC helix, and the pThr423 phosphate
group, not seen in X-ray structures. The orthologous
PAK4 Arg359 fulfills the same role in immobilizing the
aChelix. These in silico predictionswere validated by
experimental mutagenesis of PAK1 and PAK4. The
simulations explain why the PAK1 A-loop phospho-
mimetic is inactive, but also point to a key functional
interaction likely found in other protein kinases.INTRODUCTION
PAKs are conserved serine/threonine kinases: of the conven-
tional p21-activated kinases (termed PAKs 1–3) PAK2 is ubiqui-
tously expressed (Bagrodia et al., 1995; Manser et al., 1995),
whereas PAK1 is brain and immune enriched. The PAKs are
expressed in all eukaryotes (Arias-Romero and Chernoff,
2008), and can be divided into two classes based on their activa-
tion (or not) by Cdc42- and Rac1-like GTPases. The conventional
group 1 PAKs exhibit phospho-transferase activity that is stimu-
lated dramatically in vitro by interaction of the Cdc42 and Rac1
interaction/binding (CRIB) domain, also found in other kinases
and non-kinases (Burbelo et al., 1995). PAKs in yeast are impor-
tant for cell morphology and cell cycle arrest (Cvrckova et al.,
1995; Zhao et al., 1995), by acting on multiple substrates to
control cytoskeletal dynamics and cell motility (Kreis and
Barnier, 2009; Zhao and Manser, 2005). PAK2 is essential forStructure 18,embryonic development in mammals, whereas PAK1 knockout
mice exhibit rather subtle defects in the central nervous and
immune systems (Asrar et al., 2009)(Allen et al., 2009). In early
development conventional PAKs act downstream of the verte-
brate-specific Cdc42-homology protein (Chp) to allow proper
E-cadherin cell-cell contacts (Tay et al., 2010).
PAK1 regulation is thought to be well understood at the
molecular level based on the crystal structure of PAK1 in an auto-
inhibited conformation that was determined to 2.3 A˚ (Lei et al.,
2000); most of the nonkinase domain is not represented in this
structure. PAK1 likely exists as a head-to-tail homo-dimer in
solution, probably in a trans-inhibited conformation, where the
autoinhibitory domain (AID) of one PAK1 molecule packs against
the C-terminal catalytic domain of the other (Parrini et al., 2002).
The binding of conventional PAKs to Cdc42.GTP or Rac1.GTP
disrupts interactions between the AID of one molecule of the
dimer and the catalytic domain of the other molecule (Parrini
et al., 2002). The AID can exhibit a Ki of 90 nM in its ability to
inhibit Cdc42-mediated PAK1 activation (Zhao et al., 1998).
Mutations to the AID can generate active forms of the kinase;
an AID segment stabilizes an open state of both the PAK1 helix
aC and the unphosphorylated activation loop (Lei et al., 2000).
The AID polypeptide (residues 83–149) in isolation can inhibit
PAKs in trans even in vivo, but this polypeptide does not bind
the active (autophosphorylated) form of the kinase (Zhao et al.,
1998). Recently we have shown that PAK1 interacts directly
through its autoinhibitory domain with the KH2 domain of the
fragile-X proteins FMR1 and FXR1 (Say et al., 2010). Thus
PAKs may have target proteins such as FMR1 that bind only to
the active kinase in its ‘‘open’’ state.
The binding constants of Cdc42 to peptides encompassing
the CRIB region are in the range 10–50 nM (Thompson et al.,
1998). These polypeptides are useful affinity reagents for assay-
ing the nucleotide status of Rac and Cdc42 in cell lysates
(Benard et al., 1999) and for Fo¨rster resonance energy transfer
experiments (Graham et al., 2001). Structural data (Gizachew
et al., 2000; Lei et al., 2000; Morreale et al., 2000) and biochem-
ical studies (Benner et al., 1995; Buchwald et al., 2001; Chong
et al., 2001; Gatti et al., 1999; Tu and Wigler, 1999; Yu et al.,
1998; Zenke et al., 1999; Zhao et al., 1998) suggest that GTPase
binding causes a major change (in conformation) that drives
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Experimental and MD Investigation of PAK Kinases(Lei et al., 2000). A single residue in the catalytic domain (equiv-
alent to human PAK1 Thr423) in the activation loop is important
both for maintaining relief from autoinhibition, and for full cata-
lytic function toward exogenous substrates (Gatti et al., 1999;
Yu et al., 1998; Zenke et al., 1999). Substitution of T423 with
glutamic acid (i.e., phospho-mimetic) has been widely used to
generate ‘‘active’’ forms of PAK1 that are thought to act indepen-
dently of Rho GTPases, for example (Bagheri-Yarmand et al.,
2000; Dharmawardhane et al., 2000; Gorlach et al., 2005;
Grassart et al., 2008; Hullinger et al., 2001; Illes et al., 2006;
Johnston et al., 2003; Schurmann et al., 2000; Thullberg et al.,
2007; Vadlamudi et al., 2000; Yoshii et al., 2001). PAK1 phos-
phorylation at Ser144 within the autoinhibitory domain contrib-
utes to kinase activation and/or maintenance of kinase activity,
but none of the other conserved autophosphorylation sites
seem to do so (Chong et al., 2001).
In this study, we challenge the notion that the PAK1 catalytic
domain exists in an active state regardless of phosphorylation
of activation loop Thr423 (Lei et al., 2005). Our investigations first
show that the widely used PAK1(T423E) phospho-mimetic is not
active in vivo. Using molecular dynamics (MD) simulations of the
kinase domain, we uncover a series of interactions not seen in
the crystal structure, including direct interactions between
Lys308 at the end of the helix aC and the activation loop phos-
pho-Thr423, which promotes packing of N- and C-lobes into
an active conformation. These findings have been extended to
reassess the active state of PAK4 where we suggest Arg359
plays a similar role. Mutation of a Q358P adjacent to this Arg
(equivalent to the PAK1 Pro307), to break the PAK4 aC helix sug-
gested by the X-ray based model to block an active state
(Eswaran et al., 2007), does not affect PAK4 activity. These find-
ings validate the use of MD simulations to explore the functional
conformational space available to protein kinases, and in partic-
ular investigate how kinase phosphorylation can alter the orien-
tation of certain key regions such as the aC helix.
RESULTS AND DISCUSSION
PAK1(T423E) Is Not Constitutively Autophosphorylated
In Vivo
PAK kinases were first identified as being activated by interac-
tion with active forms of the small GTPases Cdc42 and Rac1,
leading to their autophosphorylation and thus activation (Manser
et al., 1995; Manser et al., 1994). A number of other Cdc42 and
Rac1-related GTPases can bind to and activate the kinase
(Knaus et al., 1995). Constitutively active versions of PAK1
have been derived that contain mutations either in the N-terminal
autoinhibitory domain cf. PAK1(L107F) (Brown et al., 1996) or
other residues in this region (Zhao et al., 1998), but many more
studies use PAK1 with phospho-mimetic Glu in place of
Thr423, the only residue to be modified in the catalytic domain
(Dharmawardhane et al., 2000; Schurmann et al., 2000). The
cellular activity of this second class of mutant is not well estab-
lished because in most cases activity was determined in vitro;
nonetheless PAK1(T423E) has been widely used, including in
transgenic mice (Li et al., 2002; Wang et al., 2002). PAK1 and
PAK1T423E ‘‘activity’’ is notoriously difficult to measure in vivo;
protocols include kinase renaturation after gel electrophoresis,
and measurement of [32P] incorporation as a surrogate for880 Structure 18, 879–890, July 14, 2010 ª2010 Elsevier Ltd All rightsubstrate phosphorylation (see Schurmann et al., 2000 for
example). For simplicity throughout our study, we will refer to
PAK1 mutants by their human numbering, although our
constructs are derived from rat cDNA.
One would anticipate that if PAK1(T423E) exhibited (even
partial) activity in mammalian cells, one could detect this using
phospho-specific antibodies directed toward the PAK1 auto-
phosphorylation sites; these being the most proximal
‘‘substrate,’’ of which Ser57 and Ser198 are the most heavily
phosphorylated (Chong et al., 2001). Surprisingly, when we ex-
pressed PAK1(T423E) in COS7 cells there was no detectable
pSer199/204 signal, but both wild-type (WT) and phospho-
mimetic kinase can undergo autophosphorylation in response
to cotransfection of Cdc42(G12V) (Figure 1B). In mammalian
cells, it is of course the balance of kinase autophosphorylation
versus phosphatase-mediated dephosphorylation that deter-
mines the degree of phosphorylation detected on these
N-terminal sites. PAK1 is counteracted primarily by PP2Ca
in vivo (Chan et al., 2008). We can conclude that contrary to
current models, PAK1(T423E) is not constitutively active in
mammalian cells, but can be activated by Cdc42.GTP to
undergo autophosphorylation. Intramolecular phosphorylation
(of these N-terminal sites) actually does not require prior activa-
tion loop Thr423 phosphorylation in vitro (Chong et al., 2001).
In vivo PAK dimers are bound to an adaptor protein PIX, which
itself is organized as a trimer (Manser et al., 1998; Schlenker and
Rittinger, 2009) suggesting that the protein complex that also
includes GIT1 might be hexameric. The most comprehensive
dynamic analysis of PAK2 activation (Hsu et al., 2008) concludes
that the PAK2 does not transit to a monomeric form on full
autophosphorylation (including pThr402) because by gel filtra-
tion the fully active kinase exhibits an apparent size gel filtration
of 130 kDa (with 7–8 phosphates) versus 116 kDa for the inac-
tive PAK2. Whether Cdc42-mediated activation of PAK1 or PAK2
really drives a ‘‘monomeric’’ state (Parrini et al., 2002) is thus
controversial.
PAK1 and PAK2 encoding plasmids are toxic and are only
propagated in certain strains of Escherichia coli. In the XL-1
blue strain kinase activity affects cell growth (Manser et al.,
1997; Pirruccello et al., 2006). The toxicity order of full-length
kinases are PAK2 > PAK1 > PAK3; in our hands none of these
catalytic domains can be expressed in E. coli, even in permissive
strains such as JM109 (data not shown). Figure 1B illustrates that
E. coli (XL-1 blue) containing WT PAK1 are unable to grow at
37C, but it is notable that PAK1(T423E) behaves in this context
as two inactive variants PAK1(K299A) and PAK1(T423A). Thus
growth in E. coli provides an excellent in vivo correlate to the
activity seen in mammalian cells.
Purified PAK1(T423E) Has Low Activity In Vitro
With respect to the phosphorylation of Thr423, which is most
likely an autophosphorylation event in vivo, and the phosphory-
lated PAK2 kinase domain may drive this process by itself
dimerizing (Pirruccello et al., 2006). Thus PAK kinases are poised
for trans-phosphorylation once the N-terminal KID is disen-
gaged. The notion that PAKs form monomers on N-terminal
binding to Cdc42 is attractive (Lei et al., 2005; Parrini et al.,
2002) but has been seriously questioned (Hsu et al., 2008). The
putative asymmetric PAK2 dimerization interface is completelys reserved
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Figure 1. PAK1 (T423E) Is Not Constitutively Active in Mammalian
Cells
(A) Plasmids encoding rat Flag-PAK1 or Flag-PAK1 (T423E) coexpressed with
or HA-Cdc42v12 as indicated in COS-7 cells. The cells were lysed and 20 mg or
40 mg of each sample (more lysate was used for samples with Cdc42 expres-
sion to compensate for PAK1 turnover). Anti-PAK1 and anti-Flag antibodies
were used to show the expression level of each individual construct. Phos-
phorylation of PAK1 by Cdc42(G12V) was shown with anti-PAK1pS198 anti-
body.
(B) Bright field micrographs of E. coli colonies grown overnight at 37C carrying
ampicillin-resistant plasmids encoding the pXJ-Flag PAK1 as indicated; KD =
K299A; TA = T423A; TE = T423E. Scale bar represents 1 mm.
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mutagenesis (Pirruccello et al., 2006). Full-length PAK1 and
PAK1(T423E) can be purified from bacteria (Figure 2) and are
extensively modified on N-terminal autophosphorylation sites
(Chong et al., 2001), likely because of the lack of relevant phos-
phatases. Baculovirus expressed PAK2 catalytic domain protein
has similar activity to the full-length autophosphorylated enzyme
(Wu and Wang, 2003). Autophosphorylation occurs at PAK1Structure 18,Ser57, Ser144, and Ser199/203 (human numbering). Using
phospho-specific antibodies to these sites one can see that re-
combinant purified GST-PAK1 is equally modified at these resi-
dues (Figure 2A). The pSer144 within the AID contributes to
PAK1 activation (Chong et al., 2001). Interestingly the WT can
adopt two different conformations in the gel. The activity of this
autophosphorylated PAK1 toward a peptide substrate fused to
GST (Figure 2B), showed that PAK1(T423E) has negligible
activity at physiological magnesium ion concentration (1 mM).
We also tested the effect of including recombinant Cdc42.GTP
in assays of recombinant PAK1 activity (Figure 2C). As for the
behavior of PAK1 in mammalian cells, Cdc42.GTP could
promote PAK1 autophosphorylation with both wild-type (WT)
and phospho-mimetic (TE) kinase, but the activity of PAK1(TE)
toward test substrate remained poor. Thus under these in vitro
conditions even the Cdc42. PAK1(T423E) complex is fundamen-
tally compromised with respect to its kinase activity. These
results are at odds with PAK1(T423E) being a ‘‘constitutively
active’’ kinase as suggested initially (Bagheri-Yarmand et al.,
2000; Dharmawardhane et al., 2000; Schurmann et al., 2000).
When one revisits these original studies the biochemistry of the
PAK1(T423E) is not well worked out, nor the mutant kinase
compared directly with fully active PAK1(pT423).
Recombinant PAK1 kinases were tested in the presence of
varying substrate concentration to determine if the primary
defect with PAK1(T423E) might relate to substrate affinity (in
30 mM Mg2+). Our experiments used kinases preactivated by au-
tophosphorylation before addition of substrate: both PAKT423A
and PAKT423E demonstrated low activity even at high substrate
concentration (see Figure S1 available online). Based on these
experiments, the calculated substrate KM with PAK1(T423E) is
perhaps 2-fold higher compared with PAK1pT423, and these
are in line with values reported for PAK2 of 20–30 mM (Jung
and Traugh, 2005): thus PAK1(T423E) has reduced catalytic
Vmax, with some effect on substrate affinity. The in vitro data of
kinase activity thus confirms the in vivo analysis based on
PAK1(T423E) autophosphorylation (Figure 1) suggesting a re-
evaluation of the existing literature based on this mutant. The
ability of Cdc42-like kinases to activate PAK1(T423E) would
argue that such effector coupling takes place in cells overex-
pressing PAK1(T423E), and indeed those studies reporting
enhanced ‘‘PAK1 effects’’ with high levels of PAK1(T423E) could
arise from its basal activity and/or an ability still to be enhanced
by binding Cdc42 and Rac1. On the other hand, if the level of
the PAK1(T423E) transgene were lower, it might behave in domi-
nant inhibitory fashion—like the kinase-inactive PAK1(K299R).
Indeed, one study reports that MDCK cells expressing (human)
PAK1(T423E) or (PAK1(K299R) have an identical phenotype
with respect to the effects of PAK1 on contact inhibition (Zegers
et al., 2003).
Although PAK2(T402E) has been described as active (Jung
and Traugh, 2005), aspects of its behavior are consistent with
this being inactive; for example active PAKs are poorly ex-
pressed in mammalian cells (Weisz Hubsman et al., 2007) unlike
PAK2 (T402E) in this study (Jung and Traugh, 2005). Recombi-
nant PAK2 exhibits enzymology consistent with both randomly
and compulsorily ordered mechanisms (Wu et al., 2003). The
k(cat) is suggested to be limited by both phosphoryl-transfer
(30 s1) and the product release (20 s1). Comparing peptide879–890, July 14, 2010 ª2010 Elsevier Ltd All rights reserved 881
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Figure 2. PAK1(T423E) Has Low Activity In Vitro
(A) Recombinant GST-PAK1 and T422 variants as indicated were resolved by SDS-PAGE (100 ng kinase per lane) and tested for modification using antibodies
directed to conserved autophosphorylation sites on PAK1. The same exposure time (10 s) is shown.
(B) Recombinant PAK1 or PAK1 (T423E) was incubated with the GST-peptide substrate (PAK1-AL, GSKRST*MVGS) and the kinase assay was carried out under
standard conditions using a final concentration of MgCl2 as indicated.
(C) Effect of Cdc42(G12V) on the activity and autophosphorylation of PAK1 and PAK1(T423E). The kinase reaction (50 ml) contained 100 ng of GST-PAK1, 1 mg
GST-Cdc42(G12V), and 10 mg of GST-Raf1 S338 peptide (RGQRDS*SYYWE), and was incubated under standard conditions. After SDS-PAGE the gel was dried
and exposed for 4 h. The PAK1 kinase autophosphorylation represents a 16-h exposure.
(D) The PAK1 kinase assay was carried out with recombinant GST-PAK1 or GST-PAK1T423E (100 ng), using GST-AL substrate (10 mg per reaction), and varying
concentration of ATP, with fixed [g-32P]ATP per reaction. The dried gel was exposed to film for 1 h (top panel) or 4 h (middle panel).
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release was much faster with the peptide (90 s1). In this study,
we use a PAK1 phosphorylatable peptide fused to glutathione-
S-transferase (a dimer of 52 kDa).
MS Simulation of the Phosphorylated PAK1 Catalytic
Domain
The active (phosphorylated) catalytic domain (c) of PAK1 or
PAK2 cannot be made in E. coli due to intrinsic toxicity of the
(unregulated) kinase (Manser et al., 1997; Pirruccello et al.,
2006). Using full-length kinase to phosphorylate an inactive
version of PAK2-c (catalytic domain) Pirruccello et al. (2006)
found that the TROSY correlation spectrum of the phosphory-
lated PAK2-c is poor unless substrates are added to disrupt
the asymmetric PAK2-c dimer.
The ATP binding pocket of kinases is highly conserved; we
created a model with a phospho-T423 version of PAK1-c bound
to ATP and a typical peptide substrate. The catalytic core of
protein kinases comprises two domains termed the kinase
N- and C-lobes. The cofactor Mg2+.ATP binds to a cleft between
the two lobes with a typical glycine-rich loop that regulates ATP
binding and ADP release (Aimes et al., 2000). It has been repeat-882 Structure 18, 879–890, July 14, 2010 ª2010 Elsevier Ltd All rightedly observed that the N-lobe helix, aC is a key regulatory
element as the center of this helix contains a conserved gluta-
mate residue (PAK1 Glu315) that forms an ion pair with a lysine
residue (PAK1 Lys299), which in turn coordinates the ATP
a- and b-phosphates to promote g-phospho-transfer. This aC
helix often interacts with the underlying DFG motif involved in
nucleotide binding. The proximity of aC helix to the active site
and activation loop explains its central role in kinase regulation
(Jeffrey et al., 1995; Sicheri and Kuriyan, 1997). The active state
of kinases comprises a ‘‘closed lobe’’ conformation with the
structured activation loop able to participate in substrate recog-
nition, and the aC helix priming the active site lysine. Crystal
structures of inactive kinases exhibit a larger diversity of confor-
mations, with at least one of the key regulatory elements missing
(Huse and Kuriyan, 2002). The X-ray structures of the isolated
PAK1-c (Lei et al., 2005) and in complex with the kinase inhibitory
domain (Lei et al., 2000) suggest PAK1 is no different from other
S/T kinases with respect to the role of the aC helix. Because
inactive PAK1-c(K299R) and the constitutively active PAK1-c
(T423E) looked very similar (Lei et al., 2005), the authors
concluded PAK1 is ‘‘primed’’ for activity with removal of the
AID to allow substrate phosphorylation. Based on our reviseds reserved
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Figure 3. Results of MD Simulations of Active PAK1
(A) A representative snapshot of the native PAK1 (pT423)-Mg-ATP-substrate
complex from the final 10 ns of the MD simulation. The kinase is shown in green
whereas the substrate peptide backbone is shown in blue cartoon representa-
tion. The magnesium ions are shown as white spheres and ATP in stick repre-
sentation. The electrostatic and hydrogen bonding network originating from
pT423 (not labeled) acts to clamp the N- and C-lobes into an active conforma-
tion primarily through interactions between Lys308 and the phosphate. Inter-
actions extend to Glu252 in the overlying helix mediated via Glu310 and
Lys309.
(B) Comparison of the N-lobe orientation of the key residues involved in activa-
tion of the ATP for phosphate transfer. A representative snapshot from the MD
simulation (green) was aligned with the X-ray structure (1YHV, yellow) using the
backbone coordinates of the C-lobe. The dynamic picture of this region can be
assessed in Movie S4. Note the large shift in the position of Lys299 toward the
bound ATP compared with Arg299 in the crystal structure (1YHV). By contrast
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Structure 18,view of this relationship in vivo and in vitro (Figure 1), we infer
a very different active state must exist.
PAK1-c was subjected to MD simulations and analysis based
on the 1.8 A˚ crystal structure (Lei et al., 2005) as described in
Experimental Procedures. The template for the starting structure
of the PAK1(pT423)-c made use of the position of the activation
loop phosphate in nonconventional PAKs (Eswaran et al., 2007).
The simulations were carried out with an unprotonated phos-
phate on the serine or threonine side chain. Such models used
have been extensively parameterized as part of the CHARMM
force field (e.g., MacKerell et al., 2000). The MD simulation was
run for the equivalent of 20 ns (yielding 20,000 sets) for each of
the three forms of the kinase: PAK1(pT423), PAK1(T423E), and
PAK1(T423A), with essentially the same overall starting struc-
ture. The behavior of the PAK1 pT423 during the 10–20 ns
portion of the simulation is summarized in Figure 3A (however,
it is essential to visualize kinase dynamics to appreciate the inter-
actions—see Movie S1). In common with other kinases (Taylor
et al., 1993), we observe a network of interactions originating
from the activation loop through hydrogen-bonds from the phos-
pho-threonine primarily driven by an interaction with Lys308
(as illustrated in Figure 3A). All three oxygens of the ionized
phosphate moiety were H-bonded to donor atoms from Arg388,
Arg421, and Lys308, during the simulations with lifetimes ranging
from 42%–90%.
The PAK1(T423E) mutant is able to hydrogen bond to Arg388
and Arg421 as observed in the crystal structure, which stabilizes
both the ‘‘DFG’’ strand and local movement of the activation loop
(Figure 4A). What is significant and missing from the X-ray struc-
tures is the interaction between T423-phosphate and Lys308 at
the start of the aC helix. This interaction then allows Glu310
bonding to Lys309 and with Glu252 in the overlying helix.
In the crystal structure Lys308 points toward the ATP binding
site. By contrast simulations of PAK1(T423A) and PAK1(T423E)
using identical starting positions (Movies S2 and S3), show the
aC helix largely disconnected from the activation loop, without
coupling between Lys308 and Glu243 or Ala423, as we discuss
in the next section. A comparison between the X-ray structure
and the PAK1 pT423 MD simulation is extremely informative
(Movie S4): using the C-lobe to align the backbone of the kinase
(in each frame), one can see how the MD conformation in the
N-lobe differs significantly both around the ATP binding pocket,
and with respect to the interactions at the end of the aC-helix. In
this clamped state the Glu315-Lys299-ab-ATP phosphate
bonds (dotted lines) are well maintained.Differences between MD Simulations of PAK1 pT423
and T423E Mutant
The simulations of PAK1 T423E and T423A mutants are illus-
trated in Movies S2 and S3 with the side chains of Ala423 or
Glu423 and Lys308 highlighted. The aC-helix behaves quite
differently in the absence of the Thr423-phosphate. Without
the tetrahedral anionic environment of the phosphate, the
number of H-bonding partners for E423 is diminished withthere is a smaller change in the position of Glu315 in the center of the aC helix.
All four b strands of the N-lobe that close over the ATP are shifted toward
the C-lobe.
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Figure 4. Organization of the aCHelix and the Activation LoopComparing the X-Ray Structure of PAK1(T423E) and theMDSimulation of PAK
pT423 in Complex with Mg2+.ATP
(A) The positions of the key side chains that complex to either Glu423 or pThr423 are indicated. The Glu423 and phosphate help to stabilize Arg421 and Arg388.
There is distortion of the aC helix due to Lys308 being ‘pulled’ toward the phosphate and the hydrogen bonding between Lys308 and Glu310.
(B) Dynamics of the aC helix, comparing PAK1 (pT423), PAK1 (T423A), and PAK1 (T423E) as measured by the distance between Ser449 within the C-lobe and
Pro307 at the end of the aC helix. The positions of these two residues are illustrated in Figure S2.
(C) Growth assays of pXJ Flag-PAK1 plasmid in E. coli XL-1 blue indicates K308A behaves as an inactive kinase. Plasmids encoding the mutants indicated were
grown and purified from JM109 at 30C. Equal amounts (5 ng) were transformed into XL-1 blue and plated overnight at 37C on LB-amp plates.
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lix in PAK1(T423E) simulation exhibits high mobility due to the
unfettered motion of the N-term of the aC-helix. This failure in
aC-helix clamping via Lys308 is most certainly the main reason
for its poor biochemical performance as a kinase. Movies S2
and S3 of this and PAK1(T423A) beautifully illustrate how the
Lys308 side chain is readily uncoupled from Glu423, so aC-helix
is no longer tethered to the C-lobe; unlike the pT423 case (Movie
S1) where the Lys308 amine is continuously coupled to the
A-loop phosphate.
It is notable that in the inactive PAK1(T423A) and PAK1(T423E)
large movements of the aC (Pro307), are possible; this is in
contrast to the rather restricted rotation of the aC on the helical
axis as suggested from the crystal structure (Lei et al., 2005).
Although it was suggested that PAK1 aC motion is constrained884 Structure 18, 879–890, July 14, 2010 ª2010 Elsevier Ltd All rightby conserved hydrophobic interactions with the overlying helix
(residues 249–259) we find that there is significant movement
of this helix relative to the aC (see Movies S1–S3). To get
a view of the consequences of this loss of aC-A-loop interaction
we mapped the distance between Ser449 buried within the
C-lobe and Pro307 at the end of the aC helix in the N-lobe (see
Figure S2). The difference between the phosphorylated kinase
(black) and the nonphosphorylated version (red) is very apparent
because the Pro307 is displaced some 4 A˚ further away. The
behavior of the PAK1(T423E) is somewhat intermediate (green),
and indicates inefficient coupling of K308 to the Glu423.
The PAK1 Lys308 Promotes an Active State
When the simulated structures are compared with the static
PAK1 crystal structure (Movie S4), the orientation of boths reserved
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Figure 5. Proposed Substrate Binding Interactions of PAK1 Based on MD Simulations of PAK1 pT423
(A) Relative position of the substrate Thr(0) and the g-phosphate of ATP is compatible with phosphorylation. Scatter plot of the distances between substrate
Thr(0)OH: ATP g-phosphate (a) and Thr(0) backbone NH: ATP g-oxygen (b) over 20 ns MD simulations for pT423 (in black) and T423E (in red) shows that
the substrate and the ATP are well poised for phosphorylation.
(B) Binding mode of the substrate peptide (backbone shown in tube and side-chain shown in ball and stick representation) against the PAK1 kinase shown in
surface representation. Note that the side chain of Arg(2) lies apposed to the negative surface (red) that is not true for Lys(3). Hydrophobic surfaces involved
in binding Met(+1) and Val(+2) are clearly visible.
(C) Specific interactions between Arg(2) side chain of substrate with the residues in the PAK1 catalytic domain based on MD simulation.
(D) Comparison of torsion angle chi1 of Val(+2) as a function of time reveals that this side chain (circled in C) is more rigidly held in PAK1 pT423 (in black), in
contrast to a higher degree of freedom in the simulation with PAK1 T423A (green) or T423E (red).
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models. Coordination between Lys308 and the phosphate
serves to ‘‘clamp’’ both the aC helix and N-lobe b strands against
the ATP binding pocket. Helix aC, the only conserved helix in the
b sheet-rich N-lobe, is a mediator of conformational changes
that take place within the catalytic center. An absolutely
conserved glutamate residue (Glu91 in PKA, Glu315 in PAK1)
within this helix forms an ion pair with the lysine side chain
(Lys72 in PKA, Lys299 in PAK1) that coordinates the b and g
phosphates of ATP. The aC helix can contact the N-terminal
region of the activation loop, and is often linked to the conserved
DFG motif. These interactions promote lobe closure around ATP
to couple the conformation of the aC helix to nucleotide binding.Structure 18,Regulatory mechanisms often modulate kinase activity by
altering the orientation of helix aC (Huse and Kuriyan, 2002). In
our simulations of PAK1(pT423) the orientation of Lys299, the
ATP moiety and E315 (Figure 3B) are poised to enable phos-
pho-transfer (see also Figure 5A).
To test the notion that these MD-predicted interactions play
biologically relevant functions we then generated K308 sub-
stituted mutants of PAK1. These PAK1 constructs were then
tested for growth inE.coliXL-1 blue (Figure 4C). The PAK1(K308A)
mutant grew at 37C indicating an inactive or less active state, but
the PAK1(K308R) mutant behaved as the wild-type with respect
to cell growth, as one might expect if the arginine side chain can
couple to the phospho-threonine. This is consistent with the879–890, July 14, 2010 ª2010 Elsevier Ltd All rights reserved 885
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Experimental and MD Investigation of PAK Kinasescase of PAK4 (see below) where Arg is present at this same posi-
tion in the aC helix, and likely plays an analogous role.
Insights into PAK1 Substrate Binding
The substrate used in this simulation is a peptide sequence
derived from the activation loop of PAK1 (S4KRST0MVGT+4)
that conforms to typical PAK1 substrates (Rennefahrt et al.,
2007). We measured the distance between the Pg atom of ATP
and the hydroxyl O of the P-site Thr to evaluate the potential
for substrate phosphorylation (Figure 5A). The simulations of the
PAK1–substrate complex showed constrained dynamic states
of the P-site Thr. The scatter plot (Figure 5A) shows the distance
between Pg and substrate Thr-OH versus the backbone NH, for
both pThr423 kinase simulation (black), and phospho-mimetic
(red). The Pg-Thr-OH distance for both was similar (average
value of pThr = 3.95 ± 0.46 A˚) that is compatible with phospho-
transfer. There are some differences in the orientation, however
we conclude that differences in substrate Thr(0) position do not
underlie the inactivity of PAK1(T423E).
Previous studies have shown strong preference for Arg at
position 2 or 5, that is characteristic of many basophilic
kinases (Pinna and Ruzzene, 1996). The preference of PKA for
Arg(2) was shown to be conferred by two acidic residues in
the substrate binding groove namely Glu171 and Glu230 (Yaffe
et al., 2001). In our simulation the substrate peptide binds via
a series of electrostatic and hydrophobic interactions that
resemble PKA (Fujii et al., 2004) but are more extensive. The
side chains of Arg(2) and Val(+2) appear most constrained
during the period of the simulation, suggesting these contribute
significantly to the binding energy. Interaction energies
computed over the simulation (data not shown) show that
Arg(2) has the largest electrostatic interactions and less so
for Lys(3); Val(+2), Met(+1), and Thr(0) are held primarily by
van der Waals interactions (Figure 5B).
The Arg(2) side chain is involved with several salt bridges as
illustrated in Figure 5C, which is in line, but not identical to,
predictive studies (Zhu et al., 2005). In this study of 15 AGC
family kinases, PAKs showed a unique substrate Arg preference
at position (2), but with little basic preference at position (3).
The authors suggested (based on similarity to related kinases)
contacts by PAK1 Asp393, Glu456, and Ser351 with the
Arg(2) side chain, somewhat different from Asp393, Glu456,
Thr353, and Ser392 seen in the MD simulation. These differ-
ences likely underlie the stronger Arg(2) effect. Mutations of
PAK1 Asp393 or Glu456 lead to acute defects in PAK1 phos-
phorylation autoactivation (Zhu et al., 2005). These authors
also note neither group I or II PAKs have a strong preference
for Arg(3), setting them apart from virtually all other known
basophilic kinases. In our simulation we see that Lys(3) is
poorly constrained and forms contacts only to the backbone
carbonyl of Gln278.
A hydrophobic pocket (Figure 5B) allows for docking of the
substrate Val(+2) with room for larger hydrophobic residues
such as Phe (Rennefahrt et al., 2007). This pocket is in part lined
by the side chains of Pro307 and Lys308, which are part of the
aC helix, and whose position is most divergent comparing the
PAK1-pT and T423E versions in MD simulations. To illustrate
how the disposition of Pro307 and Lys308 affect the mobility of
Val(+2) we plotted the torsion angle against time during the simu-886 Structure 18, 879–890, July 14, 2010 ª2010 Elsevier Ltd All rightlation (Figure 5D). When phosphate is constraining Pro307 and
Lys308 (black) the Val (+2) remains fixed whereas in the TE and
TA states Val(+2) is more mobile. Met(+1) is stabilized in a hydro-
phobic pocket formed by Pro428, Met431, Leu470, and Leu473.
It is notable that a strongly basic patch lies to the right of the
substrate pocket, a potential binding site for the acidic portion
of phospho-tyrosine that is favored at +2 (Rennefahrt et al.,
2007). There is strong selection against substrates with Arg at
P(+1), P(+2), or P(+3) unlike the closely related Mst family (Zhu
et al., 2005).
Similarities between PAK1 and Nonconventional PAK4
There are a number of examples where direct coupling between
the aC-helix and the phosphorylated activation loop promotes
an active state. For example, PKA His87 hydrogen bonds to
phosphorylated Thr197: this histidine motif QIEHT is well
conserved among PKA family kinases. Such direct coupling
between aC and activation loop phosphate(s) is exemplified in
the MAP kinases. Thus the dual phosphorylated p38g is held in
an active conformation by pThr183, which forms hydrogen
bonds with five basic amino acids, to induce rotation of the
aC-helix (Bellon et al., 1999). Whether such ionic coupling of
the activation loop phosphate(s) with the aC helix is common
is something we are investigating.
Catalytic domains of PAK4/5/6 are purified with full activation
loop phosphorylation (equivalent Ser474 in PAK4, Ser602 in
PAK5, and Ser560 in PAK6). X-ray structures of these phosphor-
ylated kinase domains show large variance in the position of resi-
dues at the start of the aC helix (Eswaran et al., 2007). To make
sense of this it was suggested PAK4 achieves an active state by
an extension at the start of helix aC, essentially adding a new turn
at its N-terminus and docking the PAK4 Arg359 side-chain to the
glycine-rich loop. This mode of ‘‘helix extension’’ cannot occur in
PAK1 where Pro307, at the N-terminal of aC, ‘‘breaks’’ the helix.
In the inhibitor-bound PAK4 and PAK5 complexes there is
a closure of the kinase lobes over the ATP-mimetic inhibitors
(Eswaran et al., 2007), which resembles our active pT423
PAK1 MD state. In the PAK5-c structure (2F57) the asymmetric
dimer contains what is suggested to be both an ‘‘inactive’’ and
active state, where the latter contains bound inhibitor. In both
cases phosphorylated Ser602 forms a hydrogen bond network
with Arg600, Arg567, Tyr620, and Phe589 but significantly not
to any residue in the aC helix. It is notable that in two high reso-
lution X-ray structures PAK5 Arg487 (equivalent to PAK1 Lys308)
binds a sulfate ion, whereas PAK4 Arg359 is close to a sulfate ion
in the vicinity of pSer494 (2CDZ).
Our dynamic PAK1 (pT423)-c model indicates aC helix
Lys308phosphate interaction is stable and promotes the active
state. The analogous aC-phosphate interaction is missing in the
PAK4/5/6 structures, but there is conservation of a number of the
aC residues when aligned (Figure 6A) notably PAK4 Arg359 at
the position of PAK1 Lys308. To assess the possibility of aC-
helix-phosphate interactions, MD simulations were carried out
on PAK4 in the presence of ATP, including the peptide substrate
used for PAK1. Typical interactions observed in and around the
activation loop pS474 are shown in Figure 6B and Movie S5;
again, the in silico dynamics suggests R359 bonds to the activa-
tion loop pS494. The oxygens of the phosphate moiety on
Ser494 were h-bonded to Arg359, Arg439, Arg472, Lys423,s reserved
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Figure 6. Summary of Interactions between the A-Loop and aCHelix
Detected by MD Simulation of PAK4-Mg.ATP-Substrate Complex
(A) Sequence comparison of the aC helix region of PAK1 and PAK4. The
conserved PAK1-Glu315 and PAK4-Glu366 are highlighted in yellow. PAK1-
Lys308 and PAK4-Arg359 are in red. Other conserved residues are highlighted
in gray.
(B) Based on the MD simulation of PAK4 in complex with Mg.ATP and
substrate (see Movie S5) we propose salt bridges between the activation
loop phosphate (pS474) and Arg359 in aC as well as interaction between
Arg472 (that also coordinates to the phosphate) in the activation loop and
Glu361 of aC.
(C) The activity of PAK4 mutants toward substrate. Cos7 cell lysate (1 = 15 ml;
2 = 30 ml) containing the overexpressed catalytic domain of GST-PAK4-c (resi-
dues 300–591) was added to glutathione-Sepharose beads, and the recovered
kinase subjected to in vitro kinase reaction using 0.2 mg/ml GST-Raf1 peptide
and g32P-ATP (10 mM). Phosphorylated S338 was detected by autoradiog-
raphy. Replacement of Gln358 at the end of the aC helix with Pro had no dele-
terious effect on kinase activity compared to wild-type. By contrast the E361V
substitution reduced kinase activity. The kinase inactive PAK4 (KD) was used
as a background control.
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Structure 18,and Ser474 with lifetimes ranging from 20%–75%. In the crystal
structure, PAK4 Arg359 was suggested instead to drive an
‘‘active’’ state by coupling to the glycine-rich loop. To biochemi-
cally test how the hydrogen bonding seen in the MD contributes
to stabilizing the active state and to evaluate the activation model
based on the crystal structure (Eswaran et al., 2007), we mutated
two residues in the aC helix. By substituting Gln358 with Pro
(present at the end of the aC helix in PAK1) we created a break
in the helix extension seen in the crystal structure (Eswaran
et al., 2007). The Glu361Val tested the notion that its hydrogen
bonding to Arg472 also stabilizes the active state (see Movie
S5). The activity of the catalytic domains of PAK4(WT) and
PAK4(Q358P) and PAK4(E361V) were assayed. In Figure 6C,
we see equivalent levels of Ser474 phosphorylation in these
proteins, indicating roughly equivalent autophosphorylation (in
Cos-7 cells) versus the kinase inactive PAK4 (KD). PAK4(Q358P)
kinase was not compromised with respect to its activity, indi-
cating that helix extension is not required to promote an active
state. PAK4(E361V) exhibited lower activity; PAK4-Glu361 has
no obvious role in promoting catalysis in any of the PAK4 crystal
structures but PAK4(E361V) would be expected to exhibit lower
activity based on the notion that it helps to couple the aC helix
with the activation loop (Figure 6B). Likely PAK1 and PAK4
have very similar active states with respect to the interactions
in and around the activation loop phosphate.
In conclusion, proteins kinases are dynamic signaling
modules, exhibiting structural heterogeneity in the form of aniso-
tropic motion and conformational states that are only beginning
to be appreciated. To date, it appears kinase autophosphoryla-
tion influences both overall enzyme dynamics, and the active site
conformation that both contribute to enhanced phosphorylation
rates. Experimental studies have revealed the importance of
activation loop phosphorylation, but its regulatory role may be
quite diverse (Bossemeyer et al., 1993; Hubbard, 1997; Nolen
et al., 2004). Several roles are proposed for the A-loop phos-
phate(s), including control of the active conformation (Nolen
et al., 2004), modulation of the phosphoryl transfer step (Adams,
2003), or formation of a P(+1) substrate binding site at the
C-terminal end of the activation segment (Engh and Bosse-
meyer, 2001; Hubbard, 1997; Seifert et al., 2002), or the P(+2)
binding site as we describe here.
The high resolution all-atom dynamic structures generated in
this study of PAKs indicates crystal structures do not necessarily
capture fundamental features of protein kinase active states. We
suggest MD simulations can accurately predict interactions of
amino acids around the phosphorylated activation loop residue,
in these cases PAK1-T423 or PAK4-S474. Direct interactions of
amino acid side chains with this phosphate promote a network of
interactions that ultimately brings together kinase N- and
C-lobes, the ATP/Mg2+ complex, and promotes binding of
substrate. Somewhat unusually (in the case of PAK1) these
states cannot be structurally accessed because the active
kinase is toxic to E. coli, and not completely phosphorylated
when expressed in insect cells. In the case of PAK4 where the
activation loop residues are clearly visible in the crystal structure,
such side chain ionic interactions appear to be masked by salt
ions (Rennefahrt et al., 2007). We therefore propose that PAK1
and PAK4 families achieve an active catalytic conformation
through similar mechanisms, although the process of activation879–890, July 14, 2010 ª2010 Elsevier Ltd All rights reserved 887
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Our results also suggest that by subjecting known protein struc-
tures to such MD simulations one can extract missing functional
features, which offsets artifacts associated with crystal packing.
EXPERIMENTAL PROCEDURES
PAK1 and PAK4 Expression
Constructs encoding full-length PAK1 (rat) or PAK4 (human) cloned in the
mammalian pXJ-Flag (Zhao et al., 1998), and were routinely transformed in
JM109 and grown at 30C. The catalytic domain of human PAK4 encompasses
residues 300–591. Amino acid substitutions were introduced using the
Quickchange protocol and sequenced. Transfections in COS7 cells were
carried out with 2 mg (total) plasmid DNA with 7.5 ml of Lipofectamine 2000
(Invitrogen) incubated for 20 min in serum free medium before added to the
cells. Transfected cells were washed with PBS and lysed with 300 ml of lysis
buffer (50 mM HEPES pH 7.3, 150 mM NaCl, 1.5 mM MgCl2, 1 mM EDTA,
10 mM b-glycerophosphate, 5% glycerol) containing 0.4% Tx-100, 5 mM
DTT, 13protease inhibitor cocktail (Roche), and 1 mM sodium ortho-vanadate.
PAK1 In Vitro Kinase Assays
The substrate sequences corresponding to the PAK1 activation loop (GST-AL)
SKRSTMVGT or Raf1S338 were expressed from pGEX-4T1 in E. coli and
purified and stored as GST fusion protein (5 mg/ml). Plasmids encoding
GST-PAK1 are as previously described (Zhao et al., 1998) and fully sequenced
before transformation: recombinant kinase was purified from BL21 grown at
30C, snap frozen (2 mg/ml), and stored in 5% glycerol before use. The
concentrated PAK1 was incubated in 0.25 mM ATP 1 mM MgCl2 (30
C) for
30 min to allow full autophosphorylation. Kinase activity was initiated by add-
ing the kinase at 0.1 mM to the reaction mix in 50 ml. Kinase buffer contained
divalent MgCl2 as indicated, 50 mM HEPES pH7.3, 50 mM NaCl, 10 mM
b-glycero-phosphate, 0.05% Triton X-100 and GST-peptide, 40 mM of cold
ATP, and 2 mCi (0.2 ml) of [g32P].ATP. The reaction was carried at 30C for
20 min; 25 ml of the reaction was loaded into 11% polyacrylamide gel.
MD Simulations
All models were built using the molecular modeling package QUANTA
(ACCELRYS, San Diego, CA). The 1.8 A˚ crystal structure of the free PAK1
kinase domain; PDB code 1YHV (Lei et al., 2005) with K299R or T423E muta-
tions was used to construct the structural models of the wild-type (pT423), or
T423E and T423A mutations, with Arg299 replaced by Lys. To generate the
closed active conformation, the N-lobe (residues 249–347) and the C-lobe
(residues 348–538) of PAK1 were superposed on the N- and C-lobes of the
highly related (and active) phospho-PAK6 structure; PDB code 2C30 (Eswaran
et al., 2007). The Mg-ATP bound state was generated by using the coordinates
of Mn2AMP-PNP from the structure of protein kinase-B complexed with
a GSK3 peptide; PDB code 1O6K (Yang et al., 2002). After superimposition,
the AMP-PNP was modified into ATP and the manganese ions were changed
to magnesium. Based on the prototype kinase PKA (and many other examples)
the two metal ions occupy a primary site that chelates the b and g phosphates,
and a secondary site that chelates the a and g phosphates of ATP (Zheng et al.,
1993).The backbone of the GSK3 peptide was used to model a substrate into
the PAK1 kinase domain model, with its sequence mutated to that of the PAK1
activation loop (SKRSTMVGT) with central threonine as the phosphorylation
target. The program CHARMM (Brooks and Karplus, 1983) was then used to
add hydrogen atoms, N- and C-terminal patches to all models, and the
pT423 phosphate group to the wild-type model.
For the phosphorylated Thr423 (and Ser474 in PAK4) the models used have
been extensively parameterized as part of the CHARMM force field (e.g.,
MacKerell et al., 2000). These models have earlier been used successfully in
other simulation studies on the protein kinase A using the CHARMM force field
(Montenegro et al., 2007). It is also reassuring that other force fields (Cheng
et al., 2006; Narayanan and Jacobson, 2009) have used similar models is simu-
lations that have yielded data in close agreement with experiments. The
charge states of the phosphoryl-moieties on Thr423 or Ser474 were set at
2. Mandell et al. (2007) have shown, using detailed calculations, that the
strength of interactions between the phosphate and positively charged resi-888 Structure 18, 879–890, July 14, 2010 ª2010 Elsevier Ltd All rightdues is similar in both the 1 and the 2 states of the phosphate. The models
were then subjected to restrained energy minimization to optimize bonds and
remove any nonbonded steric clashes.
MD simulations were carried out using the NAMD package (Phillips et al.,
2005) the CHARMM22 force field at 1 atm pressure and 300 K. The optimized
models were solvated and neutralized in a box with the TIP3P water model at
a minimum of 10 A˚ between the model and the wall of the box. The simulations
were set up with 1 fs time step under periodic boundary conditions. The
particle mesh Ewald method was applied to model the electrostatics and
the van der Waals interactions cut-off was set at 12 A˚. The system was mini-
mized for 5000 steps and heated from 0 K to 300 K over 5 ps. The backbone
of protein (and peptide) was then restrained for 30 ps simulation and followed
by removing all the restraints and performing an equilibration simulation of
50 ps. The production run was simulated for 20 ns and coordinates were
stored every 1 ps. Simulations were viewed using VMD (Humphrey et al.,
1996).
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